Inhibitors of papilloma virus
AssigneeBoehringer Ingelheim International GmbH
InventorsYoula S. Tsantrizos, Anne-Marie Faucher, Jean Rancourt, Peter White
Life of this patent
Estimating the term…
Loading patent…
AssigneeBoehringer Ingelheim International GmbH
InventorsYoula S. Tsantrizos, Anne-Marie Faucher, Jean Rancourt, Peter White
Estimating the term…
The use of a compound of formula (II): or its enantiomers or diastereoisomers thereof, or salts or pharmaceutically-acceptable esters thereof, in the treatment or prevention of a papilloma virus infection, particularly human papilloma virus in a mammal, wherein R11; X4; X5; X6; R13; R14; W; Z; Y; T; and R18 are defined herein. The present invention also provides novel compounds, pharmaceutical compositions and methods for using these compounds and compositions in the treatment or prevention of papilloma virus infection. More particularly, the present invention provides compounds, compositions and methods for inhibiting papilloma virus DNA replication by interfering with the E1-E2 protein-protein interaction essential for viral DNA replication.
A compound of formula (1) or its enantiomers or diastereoisomers thereof:
Dependencies are inferred from the claim text.